UNHUNITEDHEALTH GROUP INCSEC EDGAR
Use with Claude or ChatGPT

UNITEDHEALTH GROUP INC (UNH) Overview

Financials • NYSE • CIK 0000731766

Loading...

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Market Cap
$363.00B
P/E (TTM)
22.9x
Rev Growth (TTM)
+3.3%
Net Margin (TTM)
3.5%
FCF Yield (TTM)
6.3%
FCF Margin (TTM)
5.1%
Figures as of September 30, 2026

Filings

Primary-source SEC disclosures, read end-to-end. SEC figures cite the filing they come from.

What your agent reads

Company-published material — management’s own words, not SEC-audited. Each source below is labeled so your agent knows what to verify.

Company-published, not SEC-audited

Earnings

Q3
about 1 month ago
8-K release
Revenue
$112.69B
-0.4%
Net Income
$4.11B
+75.0%
EPS
$4.56
+76.1%
Most recent quarterly earnings snapshot

Cash Flow Health

Free Cash Flow8/8 positive
TTM$22.8B
Q3 '26
$4.3B-58%
Q2 '26
$10.3B+26%
FCF Margin
TTM5.1%
Q3 '263.8%-59%
Sector: 28.4%Below Avg
OCF Margin
5.8%
OCF/NI1.65x
CapEx Coverage
7.8x
FCF Yield6.3%
FCF Growth (3Y)-5%

Cash-conversion-cycle metrics are not computed for financial-sector filers.

Cash flow trends & capital efficiency

Capital Allocation

Total Shareholder YieldTTM
TTM3.6%
Div Yield2.2%
+
Buyback (TTM)1.4%
Dividend & Payout Metrics
Dividend Yield (TTM)2.2%
FCF Payout Ratio35.5%
Free Cash Flow (TTM)$22.8B
Stock Repurchases (TTM)$5.0B
Capital Return / FCF57.8%
Shares Outstanding (YoY)-1.1%↓ Buyback
Est. Dividends Paid (TTM)$8.1B
Shows how management rewards shareholders

Valuation Metrics

Price-to-EarningsTTM
22.9x
8Q: 20.4x+61629%
Valuation Lenses
Earnings
22.9x
vs – sector
Cash Flow
17.9x
EV/FCF vs –
Growth-Adj
–PEG
N/A
Quality-Adj
–P/E per %ROIC
ROIC: –
Shareholder Returns
Dividend
2.2%
Buyback
1.4%
Total Yield
3.6%
Market Cap$363.00B
EV$408.78B

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Multi-angle valuation analysis with sector context

Margins & Efficiency

ROE 76th pctile
Profitability
Net Margin
3.5%
ROA
5.1%
ROTCE
-53.0%

Gross/operating margin, ROIC and the DuPont decomposition are not computed for financial-sector filers.

Return on EquityTTM
15.7%
P25MedianP75
76th pctl (med: 10.7%)
Asset & CapEx Efficiency
Fixed Asset Turn
41.62x
8Q:41.33x
+190.2%
CapEx/Depreciation
0.79x
FCF vs Net Margin Gap+1.5 pts
Margin trends, ROIC, and capital efficiency

Balance Sheet & Solvency

ND/EBITDA 1.8x
Net Debt / EBITDA
1.8xNet Debt: $45.78B
Interest Coverage
6.2x
+Strong interest coverage: 6.2x
Leverage Metrics
Debt-to-Equity
0.71x
Balance sheet risk & solvency analysis